[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362660-105":59,"doc-detail-362660-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mismatch-repair-proteins-and-cd45ro-positive-lymphocytes-in-malignant-and-benign-salivary-gland-tumors-a-favorable-association-with-disease-clinical-parameters","Mismatch Repair Proteins and CD45RO-Positive Lymphocytes in Malignant and Benign Salivary Gland Tumors - A Favorable Association with Disease Clinical Parameters","","Investigates mismatch repair (MMR) proteins, tumor-infiltrating lymphocytes (TILs), and CD45RO expression across malignant and benign salivary gland tumors. MLH1, MSH2, MSH6, and PMS2 were assessed by immunohistochemistry, and hematoxylin-eosin–stained sections were scored to quantify TIL rates. No partial or complete MMR protein loss was found. Malignant subtypes and benign tumors differed in TIL infiltration and CD45RO memory cell presence, with CD45RO+ infiltration linked to TNM stage and histological grade.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mismatch-repair-proteins-and-cd45ro-positive-lymphocytes-in-malignant-and-benign-salivary-gland-tumors-a-favorable-association-with-disease-clinical-parameters/362660/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mismatch-repair-proteins-and-cd45ro-positive-lymphocytes-in-malignant-and-benign-salivary-gland-tumors-a-favorable-association-with-disease-clinical-parameters/362660.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study objective regarding salivary gland tumors?","Question",{"text":112,"@type":113},"To examine mismatch repair (MMR) proteins, tumor-infiltrating lymphocytes (TILs), and CD45RO expression in salivary gland tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were MMR proteins and CD45RO evaluated?",{"text":117,"@type":113},"MLH1, MSH2, MSH6, and PMS2 were measured by immunohistochemistry, and hematoxylin-eosin–stained sections were scored to assess TIL rates; CD45RO was also assessed by immunohistochemistry.",{"name":119,"@type":110,"acceptedAnswer":120},"What differences were observed between malignant and benign tumors?",{"text":121,"@type":113},"Malignant tumors showed notable differences in CD45RO+ cell infiltration compared with benign tumors, and both TNM stage and histological grade were associated with the CD45RO+ infiltration status.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362660,1790170834,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article published online: 2026-03-17  \nOriginal Research 1  \nMismatch Repair Proteins and CD45RO-Positive Lymphocytes in Malignant and Benign Salivary Gland Tumors: A Favorable Association with Disease Clinical Parameters  \nHamid Ghaderi 1 Yousef Mohammadi2 Simin Ahmadvand3 Akbar Safaei4 Sajjad Gerdabi2 Fatemeh Asadian5 Bijan Khademi6 Mohammad Reza Haghshenas2 Abbas Ghaderi2  \n1 Violet Vines Marshman Centre for Rural Health Research, La Trobe Rural Health School, La Trobe University Bendigo, Bendigo, Victoria, Australia  \n2 School of Medicine, Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran  \n3 Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada  \n4 Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran  \n5 Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran  \n6 Department of Otolaryngology, Otolaryngology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran  \nInt Arch Otorhinolaryngol 2026;30(1):s00451806721 .  \nAddress for correspondence Abbas Ghaderi, PhD, Shiraz Institute for Cancer Research, Medical School, Shiraz University of Medical Sciences, Shiraz, P. O. Box: 71345-3119, Iran  \n(e-mail: [ghaderia@sums.ac.ir](ghaderia@sums.ac.ir)).  \nAbstract  \nKeywords  \n► salivary gland tumors  \n► mismatch repair proteins  \n► tumor-infiltrating lymphocytes  \n► CD45ROþ memory cells  \nIntroduction Salivary gland tumors (SGTs) are uncommon lesions that account for 3 to 6% of head and neck cancers.  \nObjective To investigate mismatch repair (MMR) proteins, tumor-inﬁltrating lymphocytes (TILs), and CD45RO expression in salivary gland tumors (SGTs) .  \nMethods Proteins MLH1, MSH2, MSH6, and PMS2 of the MMR proteins family and CD45RO were evaluated using immunohistochemistry (IHC) . Hematoxylin and eosinstained sections were scored to explore the rate of TILs.  \nResults None of the malignant and benign SGTs had partial or complete loss of at least one of the MMR proteins. Mucoepidermoid carcinomas, adenoid cystic carcinomas, salivary ductal carcinomas, and acinic cell carcinomas as malignant tumor types, and pleomorphic adenoma and Warthin’s tumors as the most common benign tumors showed considerable differences in terms of the inﬁltration of TILs and CD45RO. Malignant tumors exhibited a notable difference in the inﬁltration of CD45ROþ cells compared to benign ones. Both the tumor, node, metastasis (TNM) stage and the histological grade were shown to be linked with the inﬁltration status of CD45ROþ cells.  \nreceived  \nJune 13, 2024  \naccepted after revision January 21, 2025  \nDOI [https://doi.org/](https://doi.org/)[ ](https://doi.org/)10.1055/s-0045-1806721 . ISSN 1809-9777  \nEditor-in-Chief:Geraldo Pereira  \nJotz.  \n© 2026 . The Author(s) .  \nThis is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)).  \nThieme Revinter Publicações Ltda. , Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil  \n2 Mismatch Repair Proteins and CD45RO-Positive Lymphocytes in Salivary Gland Tumors Ghaderi et al.  \nConclusion Our results show that MMR deﬁciency might be insigniﬁcant and less relevant in SGTs. However, differences inTIL rate and CD45RO expression indicate that each of the SGT tumor types may have distinguished immune microenvironments. Malignant SGTs have higher inﬁltration of activated immune cells, and, thereby, these cells can be considered as good indicators of patient ’s status.  \nIntroduction  \nSalivary gland tumors (SGTs) encompass a wide range of neoplasms that exhibit different morphological and clinical characteristic","cbCaicv9AGSJombo","https://ap.wps.com/l/cbCaicv9AGSJombo","pdf",1766298,"English","# Introduction\n## Salivary gland tumor background and clinical context\n# Objective\n# Methods\n## Immunohistochemistry and TIL scoring","[{\"question\":\"What was the study objective regarding salivary gland tumors?\",\"answer\":\"To examine mismatch repair (MMR) proteins, tumor-infiltrating lymphocytes (TILs), and CD45RO expression in salivary gland tumors.\"},{\"question\":\"How were MMR proteins and CD45RO evaluated?\",\"answer\":\"MLH1, MSH2, MSH6, and PMS2 were measured by immunohistochemistry, and hematoxylin-eosin–stained sections were scored to assess TIL rates; CD45RO was also assessed by immunohistochemistry.\"},{\"question\":\"What differences were observed between malignant and benign tumors?\",\"answer\":\"Malignant tumors showed notable differences in CD45RO+ cell infiltration compared with benign tumors, and both TNM stage and histological grade were associated with the CD45RO+ infiltration status.\"}]","Mismatch Repair Proteins and CD45RO-Positive Lymphocytes in Malignant and Benign Salivary Gland Tumors - A Favorable Association with Disease Clinical Parameters | PDF",1790148722,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73936a5bb552db8eb1c0a14d4bd377a5.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b63d4df9a8d4dc274fa388fb25d2466.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29d08a5101b44495af967d9d63395329.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce38c318e4c8fe62a7fb43866a3b8ecc.webp",980,1301]